|
|
WHAT TO EXPECT WITH STALEVO
STALEVO is indicated for
certain patients with Parkinson's disease experiencing symptom
reemergence due to levodopa "wearing-off."
|
|
|
|
STALEVO does more than carbidopa/levodopa alone. It has been clinically proven to
deliver more active time during the day—an average of almost an hour and a half each day (1.4 hours).
So your loved one can enjoy more time with fewer symptoms.
|
|
|
This means he or she may have more time to do more and move around with greater ease. You may
notice more consistent control of symptoms with STALEVO compared to levodopa alone,
because STALEVO contains carbidopa, levodopa, and entacapone. Your loved one's results
may vary. Talk to your health care professional (HCP) if you have questions about STALEVO.
|
|
|
|
|
|
STALEVO is supplied as tablets in 6 strengths:
|
|
|
- STALEVO 50 (containing 12.5 mg carbidopa, 50 mg levodopa, and 200 mg entacapone)
- STALEVO 75 (containing 18.75 mg carbidopa, 75 mg levodopa, and 200 mg entacapone)
- STALEVO 100 (containing 25 mg carbidopa, 100 mg levodopa, and 200 mg entacapone)
- STALEVO 125 (containing 31.25 mg carbidopa, 125 mg levodopa, and
200 mg entacapone)
- STALEVO 150 (containing 37.5 mg carbidopa, 150 mg levodopa, and
200 mg entacapone)
- STALEVO 200 (containing 50 mg carbidopa, 200 mg levodopa, and 200 mg entacapone)
|
|
|
As a care partner, you can help make sure that STALEVO is taken as prescribed, doses are not
skipped, and tablets are not altered.
|
|
|
|
|
|
The person you care for will experience various symptons from day to day.
Some days are worse than others. On challenging days, try to listen and be
patient. Allow your loved one time and space to accomplish his or her own goals.
|
|
|
|
It's important to be a calming influence and to help your loved one, when appropriate.
|
|
|
|
|
 |
 |
|
|
|
|
|
Don't forget to take care of yourself
|
|
|
|
|
 |
|
|
|
|
|
Find support and resources
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
 |
Use of website is governed by the Terms of Use and Privacy Statement.
Copyright ©2013 Novartis Pharmaceuticals Corporation. All rights reserved. |
| |
|
| 4/11 - SLV-1023900 |
| |
|
